Although the different roles of HDAC isoforms in the tumor development and progression of various cancer types have been characterized, the modulation of HDAC expression in response to anticancer treatments and their involvement in the metastatic relapse after the treatment is less understood. Here, HDAC9 is linked to neoplasm.